269 related articles for article (PubMed ID: 22668349)
21. Systematic quantification of negative feedback mechanisms in the extracellular signal-regulated kinase (ERK) signaling network.
Cirit M; Wang CC; Haugh JM
J Biol Chem; 2010 Nov; 285(47):36736-44. PubMed ID: 20847054
[TBL] [Abstract][Full Text] [Related]
22. Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRAS
Ryan MB; Fece de la Cruz F; Phat S; Myers DT; Wong E; Shahzade HA; Hong CB; Corcoran RB
Clin Cancer Res; 2020 Apr; 26(7):1633-1643. PubMed ID: 31776128
[TBL] [Abstract][Full Text] [Related]
23. Sulphur doped carbon dots enhance photodynamic therapy via PI3K/Akt signalling pathway.
Li Y; Wu S; Zhang J; Zhou R; Cai X
Cell Prolif; 2020 May; 53(5):e12821. PubMed ID: 32364266
[TBL] [Abstract][Full Text] [Related]
24. Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.
Sulahian R; Kwon JJ; Walsh KH; Pailler E; Bosse TL; Thaker M; Almanza D; Dempster JM; Pan J; Piccioni F; Dumont N; Gonzalez A; Rennhack J; Nabet B; Bachman JA; Goodale A; Lee Y; Bagul M; Liao R; Navarro A; Yuan TL; Ng RWS; Raghavan S; Gray NS; Tsherniak A; Vazquez F; Root DE; Firestone AJ; Settleman J; Hahn WC; Aguirre AJ
Cell Rep; 2019 Oct; 29(1):118-134.e8. PubMed ID: 31577942
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase.
Song JH; Singh N; Luevano LA; Padi SKR; Okumura K; Olive V; Black SM; Warfel NA; Goodrich DW; Kraft AS
Mol Cancer Ther; 2018 Dec; 17(12):2710-2721. PubMed ID: 30190422
[TBL] [Abstract][Full Text] [Related]
26. Glycolysis-non-canonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment.
Qiao J; Liu S; Huang Y; Zhu X; Xue C; Wang Y; Xiong H; Yao J
J Colloid Interface Sci; 2024 Jul; 665():477-490. PubMed ID: 38429120
[TBL] [Abstract][Full Text] [Related]
27. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.
Zhang Y; Xia M; Jin K; Wang S; Wei H; Fan C; Wu Y; Li X; Li X; Li G; Zeng Z; Xiong W
Mol Cancer; 2018 Feb; 17(1):45. PubMed ID: 29455668
[TBL] [Abstract][Full Text] [Related]
28. MAPK/ERK and PI3K/AKT signaling pathways are activated in adolescent and adult acute lymphoblastic leukemia.
Loureiro G; Bahia DM; Lee MLM; de Souza MP; Kimura EYS; Rezende DC; Silva MCA; Chauffaille MLLF; Yamamoto M
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1912. PubMed ID: 37867416
[TBL] [Abstract][Full Text] [Related]
29. PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation.
Davis TB; Yang M; Schell MJ; Wang H; Ma L; Pledger WJ; Yeatman TJ
Sci Rep; 2018 Jun; 8(1):9296. PubMed ID: 29915291
[TBL] [Abstract][Full Text] [Related]
30. Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance.
Rozengurt E; Soares HP; Sinnet-Smith J
Mol Cancer Ther; 2014 Nov; 13(11):2477-88. PubMed ID: 25323681
[TBL] [Abstract][Full Text] [Related]
31. Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation.
Cosgrove BD; Alexopoulos LG; Hang TC; Hendriks BS; Sorger PK; Griffith LG; Lauffenburger DA
Mol Biosyst; 2010 Jul; 6(7):1195-206. PubMed ID: 20361094
[TBL] [Abstract][Full Text] [Related]
32. Breast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras/PI3K inhibition.
Muthuswami M; Ramesh V; Banerjee S; Viveka Thangaraj S; Periasamy J; Bhaskar Rao D; Barnabas GD; Raghavan S; Ganesan K
PLoS One; 2013; 8(10):e77553. PubMed ID: 24147022
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.
Watson GA; Zhang X; Stang MT; Levy RM; Queiroz de Oliveira PE; Gooding WE; Christensen JG; Hughes SJ
Neoplasia; 2006 Nov; 8(11):949-55. PubMed ID: 17132227
[TBL] [Abstract][Full Text] [Related]
34. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways.
Zwang NA; Zhang R; Germana S; Fan MY; Hastings WD; Cao A; Turka LA
Am J Transplant; 2016 Sep; 16(9):2624-38. PubMed ID: 27017850
[TBL] [Abstract][Full Text] [Related]
35. Drug-drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers.
Fujita H; Arai S; Arakawa H; Hamamoto K; Kato T; Arai T; Nitta N; Hotta K; Hosokawa N; Ohbayashi T; Takahashi C; Inokuma Y; Tamai I; Yano S; Kunishima M; Watanabe Y
Bioorg Med Chem; 2024 Mar; 102():117674. PubMed ID: 38457912
[TBL] [Abstract][Full Text] [Related]
36. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.
Mulholland DJ; Kobayashi N; Ruscetti M; Zhi A; Tran LM; Huang J; Gleave M; Wu H
Cancer Res; 2012 Apr; 72(7):1878-89. PubMed ID: 22350410
[TBL] [Abstract][Full Text] [Related]
37. Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins.
Domma AJ; Henderson LA; Goodrum FD; Moorman NJ; Kamil JP
J Virol; 2023 Oct; 97(10):e0056323. PubMed ID: 37754763
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of ERK1/2 or CRMP2 Disrupts Alcohol Memory Reconsolidation and Prevents Relapse in Rats.
Rahamim N; Liran M; Aronovici C; Flumin H; Gordon T; Urshansky N; Barak S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791516
[TBL] [Abstract][Full Text] [Related]
39. Sensing and integration of Erk and PI3K signals by Myc.
Lee T; Yao G; Nevins J; You L
PLoS Comput Biol; 2008 Feb; 4(2):e1000013. PubMed ID: 18463697
[TBL] [Abstract][Full Text] [Related]
40. R-Ras promotes metastasis of cervical cancer epithelial cells.
Mora N; Rosales R; Rosales C
Cancer Immunol Immunother; 2007 Apr; 56(4):535-44. PubMed ID: 16862428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
